A response to the commentary "Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms" by Loftis, J.M. on "Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms" by Udina, M., Moreno-España, J., Navinés, R., Gimenez, D., Langohr, K., Gratacòs, M., Capuron, L., de la Torre, R., Solà, R., Martin-Santos, R. http:\\dx.doi.org/10.1016/j.psyneuen.2013.03.007.
Language
EN
Article de revue
This item was published in
Psychoneuroendocrinology. 2013-09-01, vol. 38, n° 9, p. 1830-1
English Keywords
Antiviral Agents
Anxiety
Depression
Fatigue
Hepatitis C
Chronic
Humans
INDEL Mutation
Interferon-alpha
Interleukin-6
Point Mutation
Polyethylene Glycols
Recombinant Proteins
Serotonin
Serotonin Plasma Membrane Transport Proteins